Site Search
Professionals 188 results
Capabilities 65 results
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Practice Area
Class Actions & Group Litigation
Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creative and aggressive arguments, across a broad range of class, collective, coordinated, and mass actions, as well multidistrict litigation. We also have succeeded at trial in several class actions—a rare occurrence.
Practice Area
White Collar & Government Investigations
Ranked Tier 1 Nationally for “Criminal Defense: White Collar” by Best Law Firms®2025, and recognized for “Corporate Crime & Investigations: Highly Regarded – Nationwide” by Chambers USA in 2025, Winston’s White Collar & Government Investigations Practice assists individuals, companies, and organizations with government investigations and enforcement matters; related criminal and civil litigation; trials; appeals; congressional oversight; internal investigations; and compliance counseling and program development and enhancement. We are comprised of 80+ litigators, with more than a dozen former prosecutors from the SEC, Main Justice, and U.S. Attorneys’ Offices nationwide, including four former U.S. Attorneys, Regional Supervisors, and a former Assistant Director, Enforcement Division, SEC. We are known for our zealous advocacy, our unyielding commitment to our clients, and for protecting and defending clients’ interests with legal acumen that’s second to none.
Experience 18 results
Experience
|January 22, 2026
Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)
Winston & Strawn LLP advised longstanding client Sociedad Química y Minera de Chile S.A. (“SQM”) (NYSE: SQM) on its US$600 million offering of subordinated capital notes. The notes were offered in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S.The subordinated capital notes are due in 2056 and constitute SQM’s first international hybrid bond issuance, structured to be consistent with SQM’s recent UF 10 million (approximately US$ 430 million) Series S hybrid-subordinated bond issuance in the Chilean securities market. The notes bear an initial annual interest rate of 5.625% and are subject to reset on April 22, 2031 (the “First Reset Date”), and on every fifth anniversary thereafter, based on a spread over the 5-year U.S. Treasury bond rate, with interest rate step-ups on the fifth and twentieth anniversaries of the First Reset Date. The transaction closed on January 22, 2026.BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Santander US Capital Markets LLC, and Scotia Capital (USA) Inc. acted as initial purchasers of the notes.Link Capital Partners was financial advisor to SQM.SQM is a global company with a leading position in the lithium, iodine, and potassium nitrate markets. It develops and produces a diverse range of products for industries essential to human progress, including health, nutrition, renewable energy, and technology, driven by innovation and technological development.The Winston & Strawn team advising on the transaction included corporate partner Sey-Hyo Lee (New York) and foreign legal advisor Bruno M. Fiorino (New York). Partner Katherine Erbeznik (New York) advised on tax matters.
Experience
|December 12, 2025
Banesco USA acquires BayFirst Financial’s SBA loan division business
Winston represented Banesco USA in its acquisition of BayFirst Financial’s SBA lending business. Through the acquisition of the SBA lending business and a portfolio of SBA 7(a) loans, Banesco USA gains the infrastructure, expertise, and enhanced capabilities to deliver SBA lending on a national scale. It marks a significant step in the bank’s growth strategy, enabling it to expand its lending nationally, enhance the ability to better serve small and mid-sized businesses, and diversify its offerings. Banesco USA is an independent Florida state-chartered bank and is part of the Banesco International financial brand of banks operating in multiple countries. Enrique Martin, partner in Winston’s M&A Practice group, led the transaction for Banesco USA and was assisted by counsel Jennifer Olivestone and associate Caitlin Calvo.
Experience
|November 26, 2025
Winston & Strawn Represented CFS Brands in its Acquisition of Cornerstone Foodservice Group
Winston represented CFS Brands, a portfolio company of TJC, in its acquisition of Cornerstone Foodservice Group, a global leader in foodservice equipment serving both front- and back-of-house applications through a portfolio of established, innovative brands.
Insights & News 396 results
Competition Corner
|February 13, 2026
|2 Min Read
Federal Court Strikes Down New HSR Form
On February 12, 2026, the Eastern District of Texas overturned the Federal Trade Commission’s (FTC’s) new Hart-Scott-Rodino (HSR) Act notification form that has been in effect for the last year.
Recognitions
|February 12, 2026
|1 Min Read
Winston Recognized in Chambers Global 2026
Winston & Strawn was recognized in Chambers Global 2026. Chambers & Partners is a prominent UK-based publishing organization that ranks lawyers and law firms based on robust editorial research and direct conversations with lawyers and clients.
Recognitions
|February 5, 2026
|1 Min Read
Winston & Strawn Recognized in Chambers France 2026
Chambers France 2026 ranked Winston & Strawn as a leading law firm in Private Equity: Mid-Market, Pharma/Life Sciences, and Tax. Additionally, individual Winston lawyers were ranked in Banking & Finance, Pharma/Life Sciences, Private Equity, and Tax.
Other Results 20 results
Location
Opened in 2003, Winston & Strawn’s San Francisco office is located in the financial district, just down the road from the Bay Area’s technology epicenter. Our team—now 25+ lawyers strong—keeps a finger on the pulse of the rapidly evolving financial services and technology sectors, and offers support across a wide spectrum of services, including antitrust/competition, commercial litigation and disputes, government investigations and compliance, intellectual property, labor and employment, mergers and acquisitions, and product liability. The San Francisco team works seamlessly with lawyers and departments across the firm’s global network to ensure the highest quality service to our clients. With a culture that represents the Bay Area’s innovative spirit, our lawyers are regularly honored with high-profile awards and frequently recognized by publications, such as Chambers USA, The American Lawyer, the Daily Journal, and The Recorder.
Location
Winston & Strawn’s São Paulo office reflects the firm’s long-term investment in Brazil and the significant commitment of Winston’s Latin America practice group members to the country over many decades. Our fully bilingual São Paulo-based attorneys represent clients on international financing, cross-border mergers and acquisitions, corporate governance, and disputes. They also act as a relationship touch point for global clients looking to expand into Brazil, ensuring an integrated and seamless service. Our São Paulo attorneys have in-depth knowledge of the region’s legal, cultural, political, regulatory, and commercial frameworks, which have earned them recognition from Chambers Global, Chambers Brazil, Chambers Latin America, Leaders League, The Legal 500, Latinvex, IFLR 1000, and LatinFinance, among many others.
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.